Food and Drug Administration Analysis of Ticagrelor: Using Data From an Enriched Trial to Evaluate Benefit-Risk Difference in an Unstudied Population.

Tzu-Yun McDowell Melanie Blank John Lawrence Norman Stockbridge

Circulation

From Division of Cardiovascular and Renal Products, Office of Drug Evaluation I, Office of New Drugs (T.-Y.M., M.B., N.S.), and Division of Biometrics I, Office of Biostatistics, Office of Translational Sciences (J.L.), Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD.

Published: November 2016

Download full-text PDF	Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.116.024691	DOI Listing

Publication Analysis

Top Keywords

food drug

drug administration

administration analysis

analysis ticagrelor

ticagrelor data

data enriched

enriched trial

trial evaluate

evaluate benefit-risk

benefit-risk difference

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!